Ivermectin + Losartan for neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Jun 2020: Trial registered, NCT04447235
  2. 23 Jul 2020: Trial started, NCT04447235
  3. 30 Jun 2022: Trial terminated, NCT04447235

The trials

NCT04447235: Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection

State
Stopped early
Phase
Phase 2
People
77 taking part
Started
23 Jul 2020
Primary completion
30 Jun 2022
Arms
ARM B: Ivermectin plus losartan
Results
None posted
  1. 25 Jun 2020: Trial registered
  2. 23 Jul 2020: Trial started
  3. 30 Jun 2022: Trial terminated

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.